SCaBER Cells
CAD$759.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The SCaBER cell line is derived from a human squamous cell carcinoma of the urinary bladder. Originating from a 58-year-old male patient, this cell line retains many of the original tumor’s features, including its squamous differentiation. SCaBER cells display a distinct epithelial morphology with prominent intercellular connections such as desmosomes and interdigitated microvilli. These characteristics make it an excellent model for studying the pathology and progression of squamous cell carcinoma in the bladder. SCaBER cells exhibit a hypotetraploid karyotype with a highly variable chromosomal number and the presence of distinctive marker chromosomes. The male karyotype includes both X and Y chromosomes, further distinguishing it from other cell lines. Ultrastructural studies reveal abundant tonofilaments, lipid bodies, and well-developed organelles such as the Golgi apparatus and rough endoplasmic reticulum. These properties have been maintained across multiple passages, ensuring consistency for long-term studies. This cell line has been utilized in immunological research to explore tumor-specific antigens and their role in bladder cancer progression. SCaBER's squamous differentiation is a key factor for investigations into tumor-associated antigens in squamous cell carcinomas, offering insights into potential diagnostic markers and therapeutic targets. Its well-characterized molecular and phenotypic properties make it a critical resource in urological cancer research. |
|---|---|
| Organism | Human |
| Tissue | Urinary bladder |
| Disease | Bladder squamous cell carcinoma |
| Synonyms | SCABER, Scaber |
Characteristics
| Age | 58 years |
|---|---|
| Gender | Male |
| Ethnicity | African |
| Morphology | Epithelial |
| Growth properties | Adherent |
Regulatory Data
| Citation | SCaBER (Cytion catalog number 305111) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_3599 |
Biomolecular Data
Handling
| Culture Medium | EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS and 1% NEAA |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305111-260824 | Certificate of Analysis | 23. May. 2025 | 305111 |